According to the National Psoriasis Foundation's 2001 Benchmark Survey, [1]psoriatic arthritis (PA) is a specific type of arthritis that has been diagnosed in approximately 23% of those who have psoriasis. [2] PA can occur in any age group; however, in most patients, it manifests itself in patients from 30-50 years of age. On average, PA appears about 10 years after the first signs of psoriasis occur, but in about 1 of 7 people with PA, arthritis symptoms occur before any skin lesions appear. Most patients with PA also have psoriasis; patients rarely have PA without psoriasis.
See the psoriatic arthritis images below.
[IMG]file:///C:/Users/USER/AppData/Local/Temp/msohtmlclip1/01/clip_image001.jpg[/IMG]Anteroposterior radiograph of the abdomen shows fusion of the sacroiliac joints. Courtesy of Bruce M. Rothschild, MD.
View Media Gallery
[IMG]file:///C:/Users/USER/AppData/Local/Temp/msohtmlclip1/01/clip_image002.jpg[/IMG]Posteroanterior radiograph of the hands shows wrist fusion. Courtesy of Bruce M. Rothschild, MD.
View Media Gallery
See Psoriasis: Manifestations, Management Options, and Mimics, a Critical Images slideshow, to help recognize the major psoriasis subtypes and distinguish them from other skin lesions.
Stamm et al used the following 9 instruments in their analysis: Arthritis Impact Measurement Scale Short Form; Bath Ankylosing Spondylitis Disease Activity Index; Disabilities of the Arm, Shoulder, and Hand Questionnaire; Dermatology Quality of Life Index; Dougados Functional Index; Health Assessment Questionnaire (HAQ); HAQ-S (HAQ adapted for spondylarthropathies); PsA-specific Quality of Life Instrument; and Short Form 36 Health Survey. [3] They found that the impact of environmental factors, attitudes toward individuals with health problems, and loss of leisure time may represent important aspects that are not addressed through the instruments currently used to assess function in PA.
Prasad et al studied 472 psoriatic patients, 40 of whom had PA. They found that the duration of skin lesions and duration of arthropathy correlate with each other. [4] PASI scores also correlate with arthropathy.
Setty et al noted that the quality of life of patients with PA appeared similar to that of patients with rheumatoid arthritis (RA). [5] The available data on mortality in PA are conflicting, leaving unanswered questions concerning mortality. Rohekar et al found that overall, 10.2% of patients in the Toronto PA cohort developed cancer. [6] The most frequent cancers were cancers of the breast, lung, and prostate. The incidence of malignancy in the large PA cohort did not differ from that in the general population. This finding differs from that reported in Gelfand's study, in which the odds ratio of psoriasis patients developing lymphoma was higher. [7]
Mullan et al noted that early changes in serum type II collagen biomarkers predicted radiographic progression at 1 year in patients with inflammatory PA after biologic treatments. [8]
Types of PA
Five types of PA have been defined; these types can coexist, but they tend to occur separately in most cases:
· Arthritis involving primarily the small joints of the fingers or toes (asymmetrical oligoarthritis) — 55-70%
· Asymmetrical arthritis, which involves the joints of the extremities — 30-50%
· Symmetrical polyarthritis, which resembles RA — 15-70%
· Arthritis mutilans, which is a rare but deforming and destructive condition — 3-5%
· Arthritis of the sacroiliac joints and spine (psoriatic spondylitis) — 5-33%. Gladman et al noted that the definition of axial disease in PA ranges from isolated unilateral grade 2 sacroiliitis to criteria similar to the criteria used for making a diagnosis of ankylosing spondylitis. [9] Depending on the criteria used, the prevalence of axial disease varies from 25% to 70% of patients with psoriatic arthritis.
Preferred examination
PA is diagnosed and assessed with radiography, which is the cornerstone in assessing and monitoring inflammatory arthritides such as PA. Radiographic findings are reproducible and allow for the serial monitoring of patients. Although magnetic resonance imaging (MRI) is more sensitive, the cost of this modality makes it a second-line means for monitoring patients with PA.[10, 11, 12, 13]
Classic presentation
Classic, but not wholly pathognomonic, associations of PA include the following:
· Nail involvement such as pitting and separation from the nail bed (onycholysis), as well as yellow-pink discoloration (the oil-drop sign)
· Sausage digits (dactylitis)
· Inflammation at the sites of ligamentous and tendinous insertions (enthesopathy)
· An absence of rheumatoid factor (RF)
Psoriasis is mostly a disease of the skin wherein some stimulus leads to a hyperproliferation of skin cells, which then results in an increase in the turnover of such cells. Patients develop papules and plaques with micalike scales; such plaques have a predilection for the sacrum, elbows, and scalp. PA can lead to joint swelling and, in the most severe case, sausagelike digits. Perioperative management of tumor necrosis factor antagonists in patients with psoriasis and other inflammatory disorders has been recorded.[14] Synovitis can manifest as edema, joint effusion, or tendinitis (see Images below).
[IMG]file:///C:/Users/USER/AppData/Local/Temp/msohtmlclip1/01/clip_image003.jpg[/IMG]Dorsal view of the hands shows psoriatic rash and sausage swelling on the right second finger. Courtesy of Bruce M. Rothschild, MD.
View Media Gallery
[IMG]file:///C:/Users/USER/AppData/Local/Temp/msohtmlclip1/01/clip_image004.jpg[/IMG]Left, typical appearance of psoriasis with silvery scaling on a sharply marginated and reddened area of the skin overlying the shin. Right, thimblelike pitting of the nail plate in a 56-year-old woman who has had psoriasis for the past 23 years. Nail pitting, transverse depressions, and subungual hyperkeratosis often occur in association with psoriatic disease of the distal interphalangeal joint. Courtesy of Ali Nawaz Khan, MBBS.
View Media Gallery
Symmetrical polyarthritis with joint pain and joint swelling furnishes a single pattern of clinical manifestations that often indicates erosive progressive disease. [15] Unlike RA, PA regularly involves distal interphalangeal joints.
Andersson lesion (erosive diskovertebral lesion) can be the initial sign of pathology in axial PA. [16]
A haplotype epidemiologic association with PA involves the expression of both class I and class II human leukocyte antigen (HLA) alleles, including HLA-B13, HLA-B17, HLA-B27, HLA-B38, HLA-B39, HLA-Cw6, HLA-DR4, and HLA-DR7. HLA-27 is present in 60% of individuals with the disease, as compared with 8% of the general population.
Factors that portend a worse prognosis for patients with PA include the following:
· A strong family history of psoriasis
· Disease onset younger than age 20 years
· Expression of HLA-B27, HLA-Cw6, or HLA-DR4 alleles
· Polyarticular disease
· Erosive disease
· Extensive skin involvement
Systemic involvement can occur with ocular changes (30%), conjunctivitis, episcleritis, and keratoconjunctivitissicca. Aortic valve disease has also been described. Because of the high skin turnover, hyperuricemia and gout can coincide with psoriasis. An association with human immunodeficiency virus (HIV) infection has also been identified; in such cases, both the psoriatic eruption and PA can be severe. Celiac disease has also been reported. [17, 18, 19, 20, 21]
Bone anabolic changes can continue in PA patients, even when they are on treatment with tumor necrosis factor inhibitors (eg, infliximab) or methotrexate. [22]
Differential diagnosis
Differential diagnosis includes ankylosing spondylitis and rheumatoid arthritis of the hands and spine. Enteropathic arthritis (arthritis of inflammatory bowel disease) should also be considered, and spotted bone disease has been reported in a patient with psoriatic arthritis. [23]
Patient education
For patient education resources, see the Skin Conditions & Beauty Center, as well as Types of Psoriasis, Psoriatic Arthritis, and Psoriasis Medications.

1. National Psoriasis Foundation. Frequently asked questions: Is psoriasis linked to other diseases?. Available at http://www.psoriasis.org/about/faq/. Accessed: April 10, 2007.
2. Alamanos Y, Voulgari PV, Drosos AA. Incidence and Prevalence of Psoriatic Arthritis: A Systematic Review. J Rheumatol. 2008 May 1. [Medline].
3. Stamm TA, Nell V, Mathis M, Coenen M, Aletaha D, Cieza A, et al. Concepts important to patients with psoriatic arthritis are not adequately covered by standard measures of functioning. Arthritis Rheum. 2007 Apr 15. 57(3):487-94. [Medline].
4. Prasad PV, Bikku B, Kaviarasan PK, Senthilnathan A. A clinical study of psoriatic arthropathy. Indian J DermatolVenereolLeprol. 2007 May-Jun. 73(3):166-70. [Medline].
5. Setty AR, Choi HK. Psoriatic arthritis epidemiology. CurrRheumatol Rep. 2007 Dec. 9(6):449-54. [Medline].
6. Rohekar S, Tom BD, Hassa A, Schentag CT, Farewell VT, Gladman DD. Prevalence of malignancy in psoriatic arthritis. Arthritis Rheum. 2008 Jan. 58(1):82-7. [Medline].
7. Gelfand JM, Shin DB, Neimann AL, Wang X, Margolis DJ, Troxel AB. The risk of lymphoma in patients with psoriasis. J Invest Dermatol. 2006 Oct. 126(10):2194-201. [Medline].
8. Mullan RH, Matthews C, Bresnihan B, FitzGerald O, King L, Poole AR, et al. Early changes in serum type II collagen biomarkers predict radiographic progression at one year in inflammatory arthritis patients after biologic therapy. Arthritis Rheum. 2007 Sep. 56(9):2919-28. [Medline].
9. Gladman DD. Axial disease in psoriatic arthritis. CurrRheumatol Rep. 2007 Dec. 9(6):455-60. [Medline].
10. Luong AA, Salonen DC. Imaging of the seronegativespondyloarthropathies. CurrRheumatol Rep. 2000 Aug. 2(4):288-96. [Medline].
11. Ory PA, Gladman DD, Mease PJ. Psoriatic arthritis and imaging. Ann Rheum Dis. 2005 Mar. 64 (suppl 2):ii55-7. [Medline]. [Full Text].
12. Guglielmi G, Scalzo G, Cascavilla A, Salaffi F, Grassi W. Imaging of the seronegative anterior chest wall (ACW) syndromes. ClinRheumatol. 2008 Jul. 27(7):815-21. [Medline].
13. Azouz EM, Duffy CM. Juvenile spondyloarthropathies: clinical manifestations and medical imaging. Skeletal Radiol. 1995 Aug. 24(6):399-408.
14. Hession MT, Gottlieb AB. Perioperative management of tumor necrosis factor antagonists in patients with psoriasis and other inflammatory disorders. J Dermatolog Treat. 2010 Aug. [Medline].
15. Kleinert S, Feuchtenberger M, Kneitz C, Tony HP. Psoriatic arthritis: clinical spectrum and diagnostic procedures. ClinDermatol. 2007 Nov-Dec. 25(6):519-23. [Medline].
16. Queiro R, Tejon P, Alonso S, Alperi M, Ballina J. Erosive discovertebral lesion (Andersson lesion) as the first sign of disease in axial psoriatic arthritis. Scand J Rheumatol. 2013 Jan 14. [Medline].
17. McCarey D, McInnes IB. Psoriatic arthritis: current topics. CurrRheumatol Rep. 2007 Dec. 9(6):442-8. [Medline].
18. Healy PJ, Helliwell PS. Psoriatic Arthritis Quality of Life Instrument: An Assessment of Sensitivity and Response to Change. J Rheumatol. 2008 Jun 1. [Medline].
19. Mease PJ, Antoni CE, Gladman DD, Taylor WJ. Psoriatic arthritis assessment tools in clinical trials. Ann Rheum Dis. 2005 Mar. 64 (suppl 2):ii49-54. [Medline]. [Full Text].
20. Mease PJ, Behrens F, Boehncke WH, et al. Discussion: assessment of psoriatic arthritis. Ann Rheum Dis. 2005. 64 (suppl 2):ii69-73. [Full Text].
21. Healy PJ, Helliwell PS. Measuring dactylitis in clinical trials: which is the best instrument to use?. J Rheumatol. 2007 Jun. 34(6):1302-6. [Medline].
22. Finzel S, Kraus S, Schmidt S, Hueber A, Rech J, Engelke K, et al. Bone anabolic changes progress in psoriatic arthritis patients despite treatment with methotrexate or tumour necrosis factor inhibitors. Ann Rheum Dis. 2012 Aug 21. [Medline].
23. Sanyal K, Stuart B. Osteopoikilosis: spotted bone disease in a patient with psoriatic arthritis. J ClinRheumatol. 2010 Aug. 16(5):251. [Medline].
24. Fournie B, Margarit-Coll N, Champetier de Ribes TL, et al. Extrasynovial ultrasound abnormalities in the psoriatic finger. Prospective comparative power-doppler study versus rheumatoid arthritis. Joint Bone Spine. 2006 Oct. 73(5):527-31.
25. Candia L, Cuellar ML, Marlowe SM, Marquez J, Iglesias A, Espinoza LR. Charcot-like arthropathy: a newly-recognized subset of psoriatic arthritis. ClinExpRheumatol. 2006 Mar-Apr. 24(2):172-5.
26. Bond SJ, Farewell VT, Schentag CT, Gladman DD. Predictors for radiological damage in psoriatic arthritis: results from a single centre. Ann Rheum Dis. 2007 Mar. 66(3):370-6.
27. Healy PJ, Groves C, Chandramohan M, Helliwell PS. MRI changes in psoriatic dactylitis--extent of pathology, relationship to tenderness and correlation with clinical indices. Rheumatology (Oxford). 2008 Jan;47(1):92-5.
28. Mejjad O, Daragon A, Louvel JP, et al. Osteoarticular manifestations of pustulosispalmaris et plantaris and of psoriasis: two distinct entities. Ann Rheum Dis. 1996 Mar. 55(3):177-80. [Medline]. [Full Text].
29. Ozcakar L, Cetin A, Inanici F, Kaymak B, Gurer CK, Kolemen F. Ultrasonographical evaluation of the Achilles' tendon in psoriasis patients. Int J Dermatol. 2005 Nov. 44(11):930-2.
30. Sandobal C, Carbo E, Iribas J, Roverano S, Paira S. Ultrasound nail imaging on patients with psoriasis and psoriatic arthritis compared with rheumatoid arthritis and control subjects. J ClinRheumatol. 2014 Jan. 20(1):21-4. [Medline].
31. Poggenborg RP, Eshed I, Ostergaard M, Sorensen IJ, Moller JM, Madsen OR, et al. Enthesitis in patients with psoriatic arthritis, axial spondyloarthritis and healthy subjects assessed by 'head-to-toe' whole-body MRI and clinical examination. Ann Rheum Dis. Jan 2014. [Medline].
32. Louvel JP, Duvey A, Da Silva F, Primard E, Mejjad O, Henry J. Computed tomography of sternoclavicular joint lesions in spondylarthropathies. Skeletal Radiol. 1997 Jul. 26(7):419-23.
33. Yuan Z, Ieong FH, Jiang H, Sobel ES. Osteoarthritis and psoriatic arthritis: findings in three-dimensional biophotonics imaging. Biomed Mater Eng 2014. 2014. 24(6):3063-71. [Medline].
34. Ostergaard M, McQueen F, Bird P, et al. The OMERACT Magnetic Resonance Imaging Inflammatory Arthritis Group - advances and priorities. J Rheumatol. 2007 Apr. 34(4):852-3. [Medline].
35. Van der Heijde D, Sharp J, Wassenberg S, Gladman DD. Psoriatic arthritis imaging: a review of scoring methods. Ann Rheum Dis. 2005 Mar. 64 (suppl 2):ii61-4. [Medline]. [Full Text].
36. Weishaupt D, Schweitzer ME, Alam F, Karasick D, Wapner K. MR imaging of inflammatory joint diseases of the foot and ankle. Skeletal Radiol. 1999 Dec. 28(12):663-9. [Medline].
37. McQueen F, Lassere M, Bird P, Haavardsholm EA, Peterfy C, Conaghan PG, et al. Developing a magnetic resonance imaging scoring system for peripheral psoriatic arthritis. J Rheumatol. 2007 Apr. 34(4):859-61. [Medline].
38. Ai Lyn Tan, EijiFukuba, Nicola Ann Halliday, Steven F Tanner, Paul Emery, Dennis McGonagle. High-resolution MRI assessment of dactylitis in psoriatic arthritis shows flexor tendon pulley and sheath-related enthesitis. Ann Rheum Dis. 2015 January. 74(1):185–189. [Medline].
39. Marzo-Ortega H, McGonagle D, Rhodes LA, Tan AL, Conaghan PG, O'Connor P, et al. Efficacy of infliximab on MRI-determined bone oedema in psoriatic arthritis. Ann Rheum Dis. 2007 Jun. 66(6):778-81. [Medline]. [Full Text].
40. Morrison WB, Ledermann HP, Schweitzer ME. MR imaging of inflammatory conditions of the ankle and foot. MagnReson Imaging Clin N Am. 2001 Aug. 9(3):615-37, xi-xii.
41. Offidani A, Cellini A, Valeri G, Giovagnoni A. Subclinical joint involvement in psoriasis: magnetic resonance imaging and X-ray findings. ActaDermVenereol. 1998 Nov. 78(6):463-5.
42. McQueen F, Lassere M, Bird P, et al. Developing a magnetic resonance imaging scoring system for peripheral psoriatic arthritis. J Rheumatol. 2007 Apr. 34(4):859-61. [Medline].
43. McQueen F, Lassere M, Ostergaard M. Magnetic resonance imaging in psoriatic arthritis: a review of the literature. Arthritis Res Ther. 2006. 8(2):207. [Full Text].
44. Taccari E, Sensi F, Spadaro A, Riccieri V, Rinaldi T. Ultrasound measurements at the proximal phalanges in male patients with psoriatic arthritis. Osteoporos Int. 2001. 12(5):412-6. [Medline].
45. Kane D, Greaney T, Bresnihan B, Gibney R, FitzGerald O. Ultrasonography in the diagnosis and management of psoriatic dactylitis. J Rheumatol. 1999 Aug. 26(8):1746-51. [Medline].
46. Freyschmidt J, Sternberg A. The bullhead sign: scintigraphic pattern of sternocostoclavicular hyperostosis and pustuloticarthroosteitis. EurRadiol. 1998. 8(5):807-12.
47. Ismail E, Capo A, Amerio P, Merla A. Functional-thermoregulatory model for the differential diagnosis of psoriatic arthritis. Biomed Eng Online. 2014 Dec 11. 13(1):162. [Medline].

student name :Faris Abdulrhman Aldiqsi
ID# : 100115